▶ 調査レポート

世界の喘息治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Asthma Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の喘息治療市場規模・現状・予測(2021年-2027年) / Global Asthma Therapeutics Market Size, Status and Forecast 2021-2027 / QYR2104Z0487資料のイメージです。• レポートコード:QYR2104Z0487
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、喘息治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(吸入、非経口、経口)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・喘息治療の市場動向
・企業の競争状況、市場シェア
・喘息治療の種類別市場規模(吸入、非経口、経口)
・喘息治療の用途別市場規模(病院、クリニック)
・喘息治療の北米市場規模2016-2027(アメリカ、カナダ)
・喘息治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・喘息治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・喘息治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・喘息治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca、Boehringer Ingelheim、F. Hoffmann-La Roche、GSK、Merck、Horizon Pharma、Mitsubishi Tanabe Pharma、Sanofi、Mundipharma、Nycomed、Kissei Pharmaceutical、ALK-Abello、Array BioPharma、SAMA Pharmaceuticals、Whanin Pharmaceutical)
・結論

Market Analysis and Insights: Global Asthma Therapeutics Market
The global Asthma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Asthma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Asthma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Asthma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Asthma Therapeutics market.

Global Asthma Therapeutics Scope and Market Size
Asthma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Asthma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Inhalation
Parenteral
Oral

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
Horizon Pharma
Mitsubishi Tanabe Pharma
Sanofi
Mundipharma
GSK
Merck
ALK-Abello
Array BioPharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inhalation
1.2.3 Parenteral
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Asthma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Asthma Therapeutics Market Perspective (2016-2027)
2.2 Asthma Therapeutics Growth Trends by Regions
2.2.1 Asthma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Asthma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Asthma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Asthma Therapeutics Industry Dynamic
2.3.1 Asthma Therapeutics Market Trends
2.3.2 Asthma Therapeutics Market Drivers
2.3.3 Asthma Therapeutics Market Challenges
2.3.4 Asthma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Asthma Therapeutics Players by Revenue
3.1.1 Global Top Asthma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Asthma Therapeutics Revenue
3.4 Global Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2020
3.5 Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Asthma Therapeutics Breakdown Data by Type
4.1 Global Asthma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Asthma Therapeutics Breakdown Data by Application
5.1 Global Asthma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Asthma Therapeutics Market Size (2016-2027)
6.2 North America Asthma Therapeutics Market Size by Type
6.2.1 North America Asthma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Asthma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Asthma Therapeutics Market Size by Type (2016-2027)
6.3 North America Asthma Therapeutics Market Size by Application
6.3.1 North America Asthma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Asthma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Asthma Therapeutics Market Size by Application (2016-2027)
6.4 North America Asthma Therapeutics Market Size by Country
6.4.1 North America Asthma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Asthma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Asthma Therapeutics Market Size (2016-2027)
7.2 Europe Asthma Therapeutics Market Size by Type
7.2.1 Europe Asthma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Asthma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Asthma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Asthma Therapeutics Market Size by Application
7.3.1 Europe Asthma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Asthma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Asthma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Asthma Therapeutics Market Size by Country
7.4.1 Europe Asthma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Asthma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Asthma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Asthma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Asthma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Asthma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Asthma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Asthma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Asthma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Asthma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Asthma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Asthma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Asthma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Asthma Therapeutics Market Size (2016-2027)
9.2 Latin America Asthma Therapeutics Market Size by Type
9.2.1 Latin America Asthma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Asthma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Asthma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Asthma Therapeutics Market Size by Application
9.3.1 Latin America Asthma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Asthma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Asthma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Asthma Therapeutics Market Size by Country
9.4.1 Latin America Asthma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Asthma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Asthma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Asthma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Asthma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Asthma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Asthma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Asthma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Asthma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Asthma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Asthma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Asthma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Asthma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Asthma Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Asthma Therapeutics Introduction
11.4.4 GSK Revenue in Asthma Therapeutics Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Asthma Therapeutics Introduction
11.5.4 Merck Revenue in Asthma Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Asthma Therapeutics Introduction
11.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2016-2021)
11.6.5 Horizon Pharma Recent Development
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Company Details
11.7.2 Mitsubishi Tanabe Pharma Business Overview
11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
11.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2016-2021)
11.7.5 Mitsubishi Tanabe Pharma Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Asthma Therapeutics Introduction
11.8.4 Sanofi Revenue in Asthma Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Mundipharma
11.9.1 Mundipharma Company Details
11.9.2 Mundipharma Business Overview
11.9.3 Mundipharma Asthma Therapeutics Introduction
11.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2016-2021)
11.9.5 Mundipharma Recent Development
11.10 Nycomed
11.10.1 Nycomed Company Details
11.10.2 Nycomed Business Overview
11.10.3 Nycomed Asthma Therapeutics Introduction
11.10.4 Nycomed Revenue in Asthma Therapeutics Business (2016-2021)
11.10.5 Nycomed Recent Development
11.11 Kissei Pharmaceutical
11.11.1 Kissei Pharmaceutical Company Details
11.11.2 Kissei Pharmaceutical Business Overview
11.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
11.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2016-2021)
11.11.5 Kissei Pharmaceutical Recent Development
11.12 ALK-Abello
11.12.1 ALK-Abello Company Details
11.12.2 ALK-Abello Business Overview
11.12.3 ALK-Abello Asthma Therapeutics Introduction
11.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2016-2021)
11.12.5 ALK-Abello Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Asthma Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2016-2021)
11.13.5 Array BioPharma Recent Development
11.14 SAMA Pharmaceuticals
11.14.1 SAMA Pharmaceuticals Company Details
11.14.2 SAMA Pharmaceuticals Business Overview
11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
11.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2016-2021)
11.14.5 SAMA Pharmaceuticals Recent Development
11.15 Whanin Pharmaceutical
11.15.1 Whanin Pharmaceutical Company Details
11.15.2 Whanin Pharmaceutical Business Overview
11.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
11.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2016-2021)
11.15.5 Whanin Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Asthma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inhalation
Table 3. Key Players of Parenteral
Table 4. Key Players of Oral
Table 5. Global Asthma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Asthma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Asthma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Asthma Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Asthma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Asthma Therapeutics Market Share by Regions (2022-2027)
Table 11. Asthma Therapeutics Market Trends
Table 12. Asthma Therapeutics Market Drivers
Table 13. Asthma Therapeutics Market Challenges
Table 14. Asthma Therapeutics Market Restraints
Table 15. Global Asthma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Asthma Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Therapeutics as of 2020)
Table 18. Ranking of Global Top Asthma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Asthma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Asthma Therapeutics Product Solution and Service
Table 22. Date of Enter into Asthma Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Asthma Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Asthma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Asthma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Asthma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Asthma Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Asthma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Asthma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Asthma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Asthma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Asthma Therapeutics Product
Table 65. AstraZeneca Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Asthma Therapeutics Product
Table 70. Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. F. Hoffmann-La Roche Company Details
Table 73. F. Hoffmann-La Roche Business Overview
Table 74. F. Hoffmann-La Roche Asthma Therapeutics Product
Table 75. F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 76. F. Hoffmann-La Roche Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Asthma Therapeutics Product
Table 80. GSK Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Asthma Therapeutics Product
Table 85. Merck Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Horizon Pharma Company Details
Table 88. Horizon Pharma Business Overview
Table 89. Horizon Pharma Asthma Therapeutics Product
Table 90. Horizon Pharma Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Horizon Pharma Recent Development
Table 92. Mitsubishi Tanabe Pharma Company Details
Table 93. Mitsubishi Tanabe Pharma Business Overview
Table 94. Mitsubishi Tanabe Pharma Asthma Therapeutics Product
Table 95. Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Mitsubishi Tanabe Pharma Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Mundipharma Company Details
Table 102. Mundipharma Business Overview
Table 103. Mundipharma Asthma Therapeutics Product
Table 104. Mundipharma Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Mundipharma Recent Development
Table 106. Nycomed Company Details
Table 107. Nycomed Business Overview
Table 108. Nycomed Asthma Therapeutics Product
Table 109. Nycomed Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Nycomed Recent Development
Table 111. Kissei Pharmaceutical Company Details
Table 112. Kissei Pharmaceutical Business Overview
Table 113. Kissei Pharmaceutical Asthma Therapeutics Product
Table 114. Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Kissei Pharmaceutical Recent Development
Table 116. ALK-Abello Company Details
Table 117. ALK-Abello Business Overview
Table 118. ALK-Abello Asthma Therapeutics Product
Table 119. ALK-Abello Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 120. ALK-Abello Recent Development
Table 121. Array BioPharma Company Details
Table 122. Array BioPharma Business Overview
Table 123. Array BioPharma Asthma Therapeutics Product
Table 124. Array BioPharma Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Array BioPharma Recent Development
Table 126. SAMA Pharmaceuticals Company Details
Table 127. SAMA Pharmaceuticals Business Overview
Table 128. SAMA Pharmaceuticals Asthma Therapeutics Product
Table 129. SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 130. SAMA Pharmaceuticals Recent Development
Table 131. Whanin Pharmaceutical Company Details
Table 132. Whanin Pharmaceutical Business Overview
Table 133. Whanin Pharmaceutical Asthma Therapeutics Product
Table 134. Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 135. Whanin Pharmaceutical Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Asthma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Inhalation Features
Figure 3. Parenteral Features
Figure 4. Oral Features
Figure 5. Global Asthma Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Asthma Therapeutics Report Years Considered
Figure 9. Global Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Asthma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Asthma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Asthma Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Asthma Therapeutics Market Share by Players in 2020
Figure 14. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Asthma Therapeutics Revenue in 2020
Figure 16. Global Asthma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Asthma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Asthma Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Asthma Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Asthma Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Asthma Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Asthma Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Asthma Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Asthma Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Asthma Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Asthma Therapeutics Market Share by Region (2016-2027)
Figure 38. China Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Asthma Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Asthma Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Asthma Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Asthma Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Asthma Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Asthma Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 60. GSK Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 62. Horizon Pharma Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 63. Mitsubishi Tanabe Pharma Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 65. Mundipharma Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 66. Nycomed Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 67. Kissei Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 68. ALK-Abello Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 69. Array BioPharma Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 70. SAMA Pharmaceuticals Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 71. Whanin Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed